Matt Redlon, chair of the AI Program at Mayo Clinic, will present on agentic AI at the Mayo Clinic AI Research Summit [1].
The event focuses on how agentic AI is transitioning from a theoretical research phase into practical application. This shift is critical because it alters the speed and methodology of scientific discovery within the medical field.
The summit is scheduled for June 4–5 [1]. It will take place in Rochester, Minnesota, and will also be available to participants online [1]. Redlon said he intends to use the platform to explore the specific impacts of agentic AI on the process of research and its eventual implementation in clinical practice.
According to the Mayo Clinic, "AI is fundamentally changing the math of discovery" [1]. This suggests a departure from traditional research timelines, where human researchers manually synthesize data, toward a model where AI agents can autonomously navigate complex datasets to identify patterns.
Redlon said the goal of the summit is to address the movement of these technologies from the lab to the bedside. The discussion will center on how these systems can be safely integrated into medical workflows to enhance discovery without compromising patient safety or data integrity.
By focusing on agentic AI, the summit highlights a move beyond generative AI, which creates content, toward systems that can execute multi-step goals. This evolution represents a significant leap in how medical institutions approach the automation of scientific inquiry [1].
“"AI is fundamentally changing the math of discovery."”
The focus on 'agentic' AI marks a pivot from using AI as a passive tool for data analysis to using it as an active participant in the research process. If medical institutions like Mayo Clinic successfully move these agents into practice, it could significantly reduce the time between hypothesis and clinical validation, potentially accelerating the development of new treatments.
